News
September 20, 2022 Event
Oblique Therapeutics is attending next BioPharma America Boston
next 28-29 September 2022 In-person and Virtual Oct 4-5 2022
August 25, 2022 Event
Oblique Therapeutics will take part in the upcoming Biotechgate Digital Partnering
Virtual business development & licensing event | Aug 29 - Sep 2, 2022
July 28, 2022 News
REKRYTERING AV NY VD
July 8, 2022 News
North Point Securities agerade finansiell rådgivare i samband med
Oblique Therapeutics AB (publ.) Private Placement om cirka 28 MSEK.
July 1, 2022 News
Oblique Therapeutics offentliggör utfall i företrädesemission av tvingande konvertibler
June 23, 2022 News
Protocol from the Annual General Meeting 15th June 2022
Protokoll från årsstämma 2022 - Protocol from the Annual General Meeting 15th June 2022
June 15, 2022 News
Release from the Annual General Meeting 15th June 2022
Kommuniké från årsstämma 2022 - Release from the Annual General Meeting 15th June 2022
June 2, 2022 News
Just out – Oblique Therapeutics AB Annual Report for 2021.
Follow the link to get access to the report 2021
May 20, 2022 News
Connect with us on LinkedIn
and follow our company updates
May 20, 2022 News
Oblique therapeutics AB förlänger teckningsperiod
i den påagående företrädesemissiomen av tvingande konvertibler